Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.
2000/08/01 by M C Alessi, Marie‐Christine Alessi, Delphine Bastelica +11 · 27 citations
Medicine · Immunology and Microbiology · #Adipokines, Inflammation, and Metabolic Diseases #Blood properties and coagulation #Biomarkers in Disease Mechanisms
paper · pdf · doi:10.2337/diabetes.49.8.1374
Abstract
In adipose tissue from both obese mice and humans, plasminogen activator inhibitor 1 (PAI-1) expression has been reported to be upregulated to levels of increased plasma PAI-1. This elevated expression has been shown to be partly controlled by tumor necrosis factor (TNF)-alpha in mice. In humans, increased PAI-1 expression is associated with insulin resistance characterized by visceral fat accumulation. Therefore, the aim of this study was to investigate the expression pattern of PAI-1 and TNF-alpha (antigen and mRNA) in visceral human adipose fat in comparison with subcutaneous (SC) fat. Because transforming growth factor (TGF)-beta1 is a potent inducer of PAI-1 synthesis and has been shown to influence adipocyte metabolism, this work was extended to TGF-beta1 quantification. A total of 32 obese individuals (BMI 42 +/- 6.8 kg/m2) were investigated. Freshly collected visceral adipose tissue did not exhibit a higher content of PAI-1 or TGF-beta1 than did SC tissue. Although most of the TNF-alpha values were at the detection limit of the methods, TNF-alpha antigen was 3-fold higher and TNF-alpha mRNA was 1.2-fold higher in visceral fat. The levels of tissue TGF-beta1 antigen correlated well with those of PAI-1 antigen, regardless of the fat depot studied (SC tissue: n = 21, r = 0.72, P = 0.0006; visceral tissue: n = 20, r = 0.49, P < 0.03), and they were both significantly associated with BMI. Conversely, no relationship was observed between the levels of TNF-alpha and PAI-1 or TNF-alpha and BMI. Tissue PAI-1 levels were also significantly correlated with those of circulating PAI-1. These results describe, in severe obesity, a proportional increase in tissue PAI-1 and TGF-beta1 in visceral and SC tissues. This increased PAI-1 expression could be the result of tissue cytokine disturbances, such as elevated TGF-beta1 expression.
Cited by
- Increased Basement Membrane Components in Adipose Tissue During Obesity: Links With TGFβ and Metabolic Phenotypes
- Elastin, arterial mechanics, and cardiovascular disease
- Role of a critical visceral adipose tissue threshold (CVATT) in metabolic syndrome: implications for controlling dietary carbohydrates: a review. [europepmc]
- An integrative genomics approach to infer causal associations between gene expression and disease. [europepmc]
- Adipokines and the blood-brain barrier. [europepmc]
- Thrombospondin-1 is an adipokine associated with obesity, adipose inflammation, and insulin resistance. [europepmc]
- Transplantation of adipose tissue and stem cells: role in metabolism and disease. [europepmc]
- Cellular bioenergetics as a target for obesity therapy. [europepmc]
- Adipose tissue remodeling in pathophysiology of obesity. [europepmc]
- Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions. [europepmc]
- Decreased response to inhaled steroids in overweight and obese asthmatic children. [europepmc]
- Vascular biology of metabolic syndrome. [europepmc]
- Protection from obesity and diabetes by blockade of TGF-β/Smad3 signaling. [europepmc]
- Dietary energy balance modulates epithelial-to-mesenchymal transition and tumor progression in murine claudin-low and basal-like mammary tumor models. [europepmc]
- Brown adipose tissue: Recent insights into development, metabolic function and therapeutic potential. [europepmc]
- Proteomics analysis of human obesity reveals the epigenetic factor HDAC4 as a potential target for obesity. [europepmc]
- Regulation of brown adipocyte metabolism by myostatin/follistatin signaling. [europepmc]
- Adipose tissue fibrosis in human cancer cachexia: the role of TGFβ pathway. [europepmc]
- CD206 + M2-like macrophages regulate systemic glucose metabolism by inhibiting proliferation of adipocyte progenitors. [europepmc]
- Microfibril-associated glycoproteins MAGP-1 and MAGP-2 in disease. [europepmc]
- Elastin, arterial mechanics, and cardiovascular disease. [europepmc]
- Sphingolipids in Obesity and Correlated Co-Morbidities: The Contribution of Gender, Age and Environment. [europepmc]
- Anti-Lipolysis Induced by Insulin in Diverse Pathophysiologic Conditions of Adipose Tissue. [europepmc]
- Environment and Gene Association With Obesity and Their Impact on Neurodegenerative and Neurodevelopmental Diseases. [europepmc]
- Adipocytes fail to maintain cellular identity during obesity due to reduced PPARγ activity and elevated TGFβ-SMAD signaling. [europepmc]
- A Serpin With a Finger in Many PAIs: PAI-1's Central Function in Thromboinflammation and Cardiovascular Disease. [europepmc]
- Leptin Increases: Physiological Roles in the Control of Sympathetic Nerve Activity, Energy Balance, and the Hypothalamic-Pituitary-Thyroid Axis. [europepmc]
Related